Related references
Note: Only part of the references are listed.The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors
Erik A. Nelson et al.
BLOOD (2011)
Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis
Fabrizio Vianello et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Hypoxia-Inducible Factor-1 α Expression Predicts Superior Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP
Andrew M. Evens et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
ICSBP-mediated immune protection against BCR-ABL-induced leukemia requires the CCL6 and CCL9 chemokines
Valentina Nardi et al.
BLOOD (2009)
The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence
I. Bruns et al.
LEUKEMIA (2009)
Bcr-Abl-mediated redox regulation of the PI3K/AKT pathway
R. Naughton et al.
LEUKEMIA (2009)
BCR-ABL1 alters SDF-1α-mediated adhesive responses through the β2 integrin LFA-1 in leukemia cells
Ying-Yu Chen et al.
BLOOD (2008)
Translation of the Philadelphia chromosome into therapy for CML
Brian J. Druker
BLOOD (2008)
Id1 is a common downstream target of oncogenic tyrosine kinases in leukemic cells
Winnie F. Tam et al.
BLOOD (2008)
Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosage
Jennifer A. Cain et al.
BLOOD (2007)
Quantification of change in phosphorylation of BCR-ABL kinase and its substrates in response to imatinib treatment in human chronic myelogenous leukemia cells
Xiquan Liang et al.
PROTEOMICS (2006)
Molecular profiling of CD34(+) cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML
ASM Yong et al.
BLOOD (2006)
Distinct molecular phenotype of malignant CD34+hematopoietic stem and progenitor cells in chronic myelogenous leukemia
R Kronenwett et al.
ONCOGENE (2005)
ID family of helix-loop-helix proteins in cancer
J Perk et al.
NATURE REVIEWS CANCER (2005)
Identification of CCR2, flotillin, and gp49B genes as new G-CSF targets during neutrophilic differentiation
S Iida et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
The development of imatinib as a therapeutic agent for chronic myeloid leukemia
M Deininger et al.
BLOOD (2005)
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia
R Ren
NATURE REVIEWS CANCER (2005)
Elevated expression of a subset of interferon inducible genes in primary bone marrow cells expressing p185 Bcr-Abl versus p210 Bcr-Abl by DNA microarray analysis
AS Advani et al.
LEUKEMIA RESEARCH (2004)
Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia
T Yasuda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Focus on myeloproliferative diseases and myelodysplastic syndromes
RA Van Etten et al.
CANCER CELL (2004)
The coupling of TEL/PDGFβR to distinct functional responses is modulated by the presence of cytokine:: involvement of mitogen-activated protein kinases
H Wheadon et al.
BLOOD (2003)
Dok-R binds c-Abl and regulates Abl kinase activity and mediates cytoskeletal reorganization
Z Master et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Chronic myelogenous leukemia molecular signature
MO Nowicki et al.
ONCOGENE (2003)
STAT5-induced Id-1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPβ
M Xu et al.
EMBO JOURNAL (2003)
Crosstalk between BCR/ABL oncoprotein and CXCR4 signaling through a Src family kinase in human leukemia cells
A Ptasznik et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Critical role for Gab2 in transformation by BCR/ABL
M Sattler et al.
CANCER CELL (2002)
TEL/platelet-derived growth factor receptor beta activates phosphatidylinositol 3 (PI3) kinase and requires PI3 kinase to regulate the cell cycle
J Dierov et al.
BLOOD (2002)
Myeloproliferative disorders with translocations of chromosome 5q31-35: Role of the platelet-derived growth factor receptor beta
EJ Steer et al.
ACTA HAEMATOLOGICA (2002)
Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells
K Ohmine et al.
ONCOGENE (2001)
The TEL/PDGFβR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways
DW Sternberg et al.
BLOOD (2001)
Expression of scinderin in megakaryoblastic leukemia cells induces differentiation, maturation, and apoptosis with release of plateletlike particles and inhibits proliferation and tumorigenesis
R Zunino et al.
BLOOD (2001)
TEL-JAK2 mediates constitutive activation of the phosphatidylinositol 3-kinase/protein kinase B signaling pathway
MHH Nguyen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Increased severity of local and systemic anaphylactic reactions in gp49B1-deficient mice
M Daheshia et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Adhesion receptors on haematopoietic progenitor cells
JYH Chan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
The collagen receptor integrins have distinct ligand recognition and signaling functions
J Heino
MATRIX BIOLOGY (2000)
TEL/PDGFβR fusion protein activates STAT1 and STAT5:: A common mechanism for transformation by tyrosine kinase fusion proteins
AM Wilbanks et al.
EXPERIMENTAL HEMATOLOGY (2000)